Evidence map›Paper›PMID 41204389›Full record

ReviewMilitary Medical Research2025

Neurogenic organ dysfunction syndrome after acute brain injury.

Heng Zhang, Wen-Jin Chen, Yan-Gong Chao, Nan Su, Chiara Robba, Marek Czosnyka, Peter Smielewski, Zofia Czosnyka, Wei He, Xiao Hu and 7 more

Abstract readReview
In one paragraph

Review in Military Medical Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Heng Zhang *Department of Neurosurgery, the First Hospital of China Medical University, Shenyang, 110001, China.
Wen-Jin Chen *Department of Neurosurgery, Neuroscience ICU, Xuanwu Hospital Capital Medical University, Beijing, 100032, China.
Yan-Gong Chao *Department of Critical Care Medicine, the First Hospital of Tsinghua University, Beijing, 100016, China.
Nan Su *State Key Laboratory of Advanced Medical Materials and Devices, School of Medicine, Tianjin University, Tianjin, 300072, China.
Chiara RobbaIRCCS for Oncology and Neuroscience, San Martino Policlinico Hospital, 16132, Genoa, Italy.
Marek CzosnykaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, CB1 0QQ, UK.
Peter SmielewskiDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, CB1 0QQ, UK.
Zofia CzosnykaDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, CB1 0QQ, UK.
Wei HeDepartment of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Xiao HuNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, 30322, USA.
De-Zhong YaoMinistry of Education Key Laboratory for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology, Chengdu, 611731, China.
Cheng-Gong HuDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Min ZhouDepartment of Critical Care Medicine, the First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, 230001, China.
Yun-Jie WangDepartment of Neurosurgery, the First Hospital of China Medical University, Shenyang, 110001, China. 19721015@cmu.edu.cn.
Xiao-Chun MaDepartment of Critical Care Medicine, the First Hospital of China Medical University, Shenyang, 110001, China. xcma2972@cmu.edu.cn.
Xiu-Yun LiuState Key Laboratory of Advanced Medical Materials and Devices, School of Medicine, Tianjin University, Tianjin, 300072, China. xiuyun_liu@tju.edu.cn.ORCID 0000-0001-9540-4865
Dong MingState Key Laboratory of Advanced Medical Materials and Devices, School of Medicine, Tianjin University, Tianjin, 300072, China. richardming@tju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic complications are common after acute brain injury (ABI) and may trigger coagulation cascades, systemic inflammation, as well as dysfunction of the cardiovascular, respiratory, and gastrointestinal systems, etc. The pathogenesis of these systemic manifestations is multifactorial but not yet fully elucidated. This paper introduces the novel term neurogenic organ dysfunction syndrome (NODS) to characterize systemic instability arising from internal and external perturbations of the neuronal center following ABI. Elucidating the central neurogenic mechanisms of NODS is critical for early detection and prevention of complications, thereby reducing mortality and improving patient outcomes following ABI. In this paper, we explore the potential central neurogenic mechanisms of NODS from the perspective of complex brain network theory, focusing on the structural network of the central autonomic system (CAS) that maintains systemic stability, and the functional network governed by the central stress system (CSS). The CAS can be divided into the cortical autonomic network, which involves higher cortical regions, and the subcortical autonomic network, which is relatively conserved, with its main connections located in deep brain structures. The CSS is a large-scale complex network characterized by hierarchy, hubs, and modularity, which together enable the competitive optimization of functional segregation and integration. Under physiological conditions, modules (mediating functional segregation) and hubs (functional integration) within the CSS dynamically trade-off with each other to maintain the overall homeostasis. However, this balance is disrupted following pathological insults or injury, resulting in weakened functional integrity of the CSS following ABI, impaired module activity, and disturbed hub integration. This paper also demonstrates the distinct pathological manifestations arising from disturbances at different levels of the homeostatic system. Finally, this study proposes potential clinical interventions, including analgesia and sedation, neuromodulation, and receptor regulation, for early interventions and potential treatment of NODS, aiming to improve patient outcomes.

Indexed as

Brain InjuriesMultiple Organ FailureHumansAcute brain injuryHierarchical hubHierarchical modular structureNeurogenic organ dysfunction syndromeSmall-world networkSystemic homeostasis

Identifiers

PMID41204389
PMCPMC12593802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.